Menter Dermatology Research Institute

Menter Dermatology Research Institute

Comments

I have spoken to my lawyer Mr Oelof de Meyer in Pretoria this morning and he told me to contact you when I am in Dallas again, but will arrange a meeting as soon as I have landed in Dallas.
We cordially welcome you as a Speaker/Delegate to 15th International Conference on Clinical and Experimental Dermatology (CME accredited) during September 28-29, which will be held in San Antonio, Texas, USA.

Theme: Skin-in-depth: Research & Care

Website: https://dermatology.conferenceseries.com/

Email: [email protected]
Psoriasis doesn't define ME! Learn how I'm Overcoming Psoriasis. Ron Villano graciously teaches us how to live life in the moment. Learn these techniques that he demonstrates to improve your journey. Use us as your support team. Thank you for joining us for this edition of Coffee Break.
You can see Ron Zing Villano each and everyday on verizon Fios. He has the largest mental health care practice on Long Island. He employees over 40 counselors. Ron is a author of the book the Zing and he is a keynote speaker. Ron has overcome the loss of his son Michael knowing that his son is with him in spirit. He teaches you how to deal with any obstacle objectively.
This man uses humor and generosity to make people laugh. Each day is a new venture. We have so much to live for, surround yourself with people who care about you. Have a Blessed Day.

#FlauntYourFlares #7dayPowerUp #packhealth #overcomingpsoriasis #curepsoriasis #NPF50th #coffeebreak #NationalPsoriasisFoundation #TinySteps #running #PsoriasisInsideStory #spoonie #overcomingpsoriasis #NPFNVC2017

MDRI is seeking participants for new clinical trials for psoriasis, eczema, rosacea, skin cancer and other dermatology disorders. Menter Dermatology Research Institute was established to address the ongoing need for new, clinically safe and effective treatments for physically and psychologically debilitating skin diseases.

Operating as usual

Eczema (Atopic Dermatitis) Study Currently Enrolling 03/29/2022

Eczema (Atopic Dermatitis) Study Currently Enrolling

Do you know anyone suffering from moderate-to-severe AD??
We are recruiting patients for a new clinical trial in Atopic Dermatitis (Eczema). Please see our website via the link below for more details.

https://menterderm.com/eczema-atopic-dermatitis-study-currently-enrolling-2/

Eczema (Atopic Dermatitis) Study Currently Enrolling Do you know anyone suffering from eczema?? If so, we have a new clinical trial that is actively recruiting patients. Please call 855-554-6374 or use this link to notify us that you would like to be contacted. Clinical Trial Government Identifier NCT05158023. Sponsor: Aslan. Note: Qualified study par...

Diet and Psoriasis 03/29/2022

Diet and Psoriasis

We often get asked how patients with psoriasis can affect their condition through non-medicinal means. A common topic in this thread is usually how diet can affect the skin. With this in mind we wrote a blog post to discuss Diet & Psoriasis, which you can access below:
https://menterderm.com/diet-and-psoriasis/

Diet and Psoriasis A common question for psoriasis patients often involves what they can do to help with their condition outside of taking medication. One of these topics is commonly diet. Overall, the benefits of a healthy diet cannot be overstated. Ensuring that your diet is complete in allowing you to obtain the re...

FDA Approval of New Medication for Atopic Dermatitis (RINVOQ) 02/08/2022

FDA Approval of New Medication for Atopic Dermatitis (RINVOQ)

We wanted to take a moment to highlight information shared in one of our prior blog posts following the recent, January 14th, FDA approval of AbbVie’s new oral treatment for atopic dermatitis. This is an oral JAK inhibitor called upadacitinib (Rinvoq). To see the full post please use the link below.
https://menterderm.com/fda-approval-of-new-medication-for-atopic-dermatitis-rinvoq/

FDA Approval of New Medication for Atopic Dermatitis (RINVOQ) We wanted to take a moment to highlight information shared in one of our prior blog posts following the recent, January 14th, FDA approval of AbbVie’s new oral treatment for atopic dermatitis. This is an oral JAK inhibitor called upadacitinib (Rinvoq). As a quick recap of that post: Janus Kinases ...

REGISTER FOR A TRIAL 11/22/2021

REGISTER FOR A TRIAL

Do you know anyone suffering from Pemphigus Vulgaris??

If so, we have a new clinical trial that is actively recruiting patients. Please call 855-554-6374 or use this link to notify us that you would like to be contacted (https://menterderm.com/register-for-a-trial/).

Clinical Trial Government Identifier NCT04598451
Sponsor: Argenx

Note: Qualified study participants will receive study drug, related testing, and compensation for their time and travel.

This study is looking to recruit adult patients (age > 18 years), with moderate-to-severe Pemphigus Vulgaris with prior biopsy-confirmed diagnosis. This study requires weekly visits to the clinic..
https://menterderm.com/our-studies/

REGISTER FOR A TRIAL REGISTER FOR A STUDY If you are interested in being contacted regarding a study, please enter your information below. Please be sure to include the study of interest and how you would be preferred to be contacted. CONTACT INFORMATION

11/15/2021

Do you know anyone suffering from Scalp & Body Plaque Psoriasis??

If so, we have a new clinical trial that is actively recruiting patients. Please call 855-554-6374 or visit the website (https://menterderm.com/register-for-a-trial/) to notify us that you would like to be contacted.

Clinical Trial Government Identifier NCT05028582
Sponsor: Arcutis

Note: Qualified study participants will receive study foam, related testing, and compensation for their time and travel.

This study is looking to recruit adult patients (age > 18 years), with moderate scalp & body plaque psoriasis. Must have at least 10% involvement of the scalp, and a maximum of 25% of total body BSA involved.

https://menterderm.com/scalp-body-plaque-psoriasis-study-currently-enrolling/

OUR STUDIES 11/15/2021

OUR STUDIES

We are very happy to announce that MDRI recently started THREE new studies: two for Psoriasis, and one for Pemphigus!! Please follow the link below to learn more.
https://menterderm.com/our-studies/

OUR STUDIES Clinical trials allow us to help patients of today and tomorrow. We currently have 20 active clinical trials, with 3 actively recruiting patients. This page will be updated as new studies are opened. If you do not see a study for the condition you are searching for, feel free to reach out to us at 8...

Smoking & Psoriasis 07/29/2021

Smoking & Psoriasis

In the June edition of NPF Advance, there was an article featured discussing smoking and psoriasis. This was a great read which raised some interesting points. Follow the link to our blog-post about the article (a link to the full article is also provided in the blog, for anyone interested).
https://menterderm.com/smoking-psoriasis/

Smoking & Psoriasis The June edition of the NPF Advance contained an article discussing smoking and how it can affect psoriasis. They discuss how smoking can both increase your risk of developing psoriasis, as well as worsening the severity of the disease a patient experiences. Beyond this, smoking can also decrease yo...

National Psoriasis Action/Awareness Month 2021 07/27/2021

National Psoriasis Action/Awareness Month 2021

August marks the start of National Psoriasis Awareness Month, a time where we can shine a light on psoriasis, its symptoms, treatments, and support those who experience any of its manifestations.
Read more of this post here: https://menterderm.com/national-psoriasis-action-awareness-month-2021/

National Psoriasis Action/Awareness Month 2021 August marks the start of National Psoriasis Awareness Month, a time where we can shine a light on psoriasis, its symptoms, treatments and support those who experience any of its manifestations. Psoriasis affects millions of people across the world. With this in mind, it is important to reflect and....

Dr. Menter for M.D./alert Conversations in Plaque Psoriasis 07/20/2021

Dr. Menter for M.D./alert Conversations in Plaque Psoriasis

Dr. Menter recently spoke with M.D./alert regarding the approval of Cosentyx in the treatment of Plaque Psoriasis for ages 6 and up.
https://menterderm.com/dr-menter-conversations-in-plaque-psoriasis/

Dr. Menter for M.D./alert Conversations in Plaque Psoriasis Dr. Menter spoke with M.D./alert about the approval of Cosentyx in the treatment of patients age 6 and up for moderate-to-severe plaque psoriasis. He discusses the impact of this approval, particularly in the case of children and adolescents diagnosed with plaque psoriasis. Please follow the link be...

MDRI Home 07/07/2021

MDRI Home

New Website Launch

Happy July!! We hope everyone had a wonderful weekend and were able to enjoy the atmosphere and fireworks.

We are happy to announce the launch of our new website!! The team have all put in a lot of hard work to renew and update everything. Please feel free to stop in and have a look around!!
https://menterderm.com/

MDRI Home At the Forefront of Research Menter Dermatology Research Institute was established to address the ongoing need for new, clinically safe and effective treatments for physically and psychologically debilitating skin diseases. Learn More OFFICE HOURS Monday - Friday

06/29/2021

National Psoriasis Foundation COVID-19 Task Force Updated Guidance for Management of Psoriatic Disease, May 2021:

The National Psoriasis Foundation Task Force met to update the guidance for the management of psoriatic disease in the context of the COVID-19 pandemic. This task force consists of 18 physicians who review new literature on a weekly basis. The expertise of these physicians range from dermatology to rheumatology, epidemiology, infectious disease and critical care.

The original 22 guidelines statements have been updated with new scientific evidence, and 5 new items have been added. It is important to note that these are not comprehensive guidelines, this is considered a live document, and evidence in some cases is limited in quality or quantity. These guidelines have been divided into 5 categories based on 5 questions (see below). Summaries of guidelines provided under each question:

1) What are the effects of psoriatic disease itself on severe acute respiratory syndrome COVID-19 infection and COVID-19 illness?
Patients with psoriatic disease appear to have similar rates of infection and similar outcomes to the general population. The likelihood of poor outcomes are driven by age and comorbidities such as heart/lung/kidney disease or metabolic disorders (diabetes/obesity).

2) What are the effects of psoriasis or PsA treatment on COVID-19 infection and illness?
Reaffirmed that treatments for psoriasis and psoriatic arthritis do not alter the risk of acquiring COVID-19, and do not affect outcomes. Patients not infected with COVID-19 are recommended to continue their biologic or oral therapies in most cases. Chronic systemic corticosteroids should be avoided if possible. Shared decision-making between patients and providers is important.

3) How should medical care be delivered to patients with psoriatic disease to lower their risk of infection with COVID-19 while still ensuring quality of care?
Telemedicine can be appropriate – short interruptions to in-person care is ok. Certain patients should always be seen, including: those where there is concern for melanoma or non-melanoma skin cancer, new psoriasis patients, and flaring patients. It is recommended that clinic staff wear masks, social distance, and perform hand hygiene.

4) What should patients with psoriatic disease do to protect themselves from becoming infected with COVID-19?
Patients should follow measures to prevent infection, including: social distancing, wearing a mask to cover the nose and mouth, hand hygiene. An mRNA vaccine (Pfizer or Moderna) is recommended for all unless contraindicated. Influenza vaccine is also recommended. Treatments for psoriasis or psoriatic arthritis can be continued during the vaccine period.

5) What should patients with psoriatic disease do if they become infected with COVID-19?
Monitor their symptoms and discuss with healthcare providers. Should be prescribed and adhere to evidence-based COVID-19 therapies. Consider a hold of psoriasis medications during an active infection – share decision making with a physician (same for resuming treatments). Patients who become infected should follow CDC guidance on home isolation. Patients in close contact with someone with COVID-19 should quarantine themselves for 14-days after last contact and discuss management of their psoriatic disease with their provider.

*Reference: Gefland et al. National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2 – Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments. Journal of the American Academy of Dermatology. May 2021

06/29/2021

Hidradenitis Suppurative Study Currently Enrolling:

Do you know anyone suffering from HS??
If so, we have a new clinical trial that is actively recruiting patients. Please call 855-554-6374 or go to https://menterderm.com/register-for-a-trial/ to notify us that you would like to be contacted.

Clinical Trial Government Identifier NCT04242446
Sponsor: UCB

Note: Qualified study participants will receive study medication, related testing, and compensation for their time and travel.

This study is looking to recruit adult patients (age > 18 years), with moderate-to-severe HS for at least 6 months. At least two different areas of the body must be affected.

06/28/2021

Eczema (Atopic Dermatitis) Study Currently Enrolling:

Do you know anyone suffering from eczema??

If so, we have a new clinical trial that is actively recruiting patients. Please call 855-554-6374 or go to https://menterderm.com/register-for-a-trial/ to notify us that you would like to be contacted.

Clinical Trial Government Identifier NCT03915496
Sponsor: Pfizer

Note: Qualified study participants will receive study medication, related testing, and compensation for their time and travel.

This study is looking to recruit adult patients (age > 18 years), with moderate-to-severe eczema for at least 1 year. The minimum of involved Body Surface Area is 10% (see picture)

Events 06/25/2021

Events

Walk For the Cure 2021:

The National Psoriasis Foundation has several fundraising and awareness spreading efforts throughout the year. A staple of these events is the annual Walk for the Cure. This is a wonderful event where the community can come together for a healthy, enjoyable walk for a great cause.
Houston and Dallas will each host this event this year (2021) and there should be participants present from Heights Dermatology, Texas Dermatology Associates as well as the Menter Dermatology Research Institute. The event will take place on 10/16/2021 in Houston, and soon after in Dallas on 11/13/2021. Please feel free to visit the National Psoriasis Foundation website (https://www.psoriasis.org/events/) here for more information about these wonderful events.
It is also important to note that August also marks National Psoriasis Action Month – please see our post (National Psoriasis Action/Awareness Month 2021 title and link) for more information. The National Psoriasis Foundation is a fantastic organization which has many ways that you can get involved, in fundraising, events and volunteering.

Events Here is a comprehensive list of all of our upcoming events. If you are looking for events in your area, you can also look in your NPF Region.

06/25/2021

Happy Clinical Trials Day 2021!!

The Menter Dermatology Research Institute would like to take this opportunity to thank all of our current and past trial participants for helping us move medicine forward! It wouldn’t be possible without you! 😊

We have been very privileged to have been involved with many trials for medications now approved for use, and available to help patients. This would not be possible without the wonderful patients who volunteer their time and effort to participate in clinical trials. Each of you has helped to advance medicine, allowing us to continue to improve treatments available for the future. Thank you so much to all of you!

For more information on Clinical Trials Day (May 20, 2021) and the first clinical trial ever, please visit: https://www.clinicaltrialsday.org/about.

Videos (show all)

Vitiligo Clinical Trial

Location

Category

Telephone

Address


3900 Junius St, #125
Dallas, TX
75246

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Other Dermatologists in Dallas (show all)
Aqua Medical Spa Aqua Medical Spa
6405 Hillcrest Ave
Dallas, 75205

Full service medical, wellness and day spa

Patrick Pownell,MD Patrick Pownell,MD
7115 Greenville Ave, Ste 220
Dallas, 75231

Patrick H. Pownell, MD, FACS is a board certified Plastic Surgeon who performs both cosmetic and reconstructive plastic surgery.

Derm Aesthetics & Laser Center Derm Aesthetics & Laser Center
7777 Forest Lane Bldg C Suite 270
Dallas, 75075

Dr. Caglia’s advanced training in cosmetic dermatologic and laser surgery combined with many years of experience ensure patients receive personalized care with the best results possible.

U.S. Dermatology Partners Cosmetics U.S. Dermatology Partners Cosmetics
Dallas, 75219

U.S. Dermatology Partners provides comprehensive general, surgical, and cosmetic dermatology nationwide.

Kassir Dermatology Kassir Dermatology
8335 Walnut Hill Lane #140
Dallas, 75231

General Dermatology and Cosmetic Dermatology located in Dallas, Texas

Orchid Rejuvenating Med Spa and Laser Center Orchid Rejuvenating Med Spa and Laser Center
16600 Dallas Parkway, Suite 406
Dallas, 75248

At Orchid Rejuvenating Med Spa & Laser Center, we specialize in the most advanced Skincare & Laser technology that combines both cosmetic and medical in a spa/clinic setting. Visit us on the web at http://www.OrchidMedSpa.com.

Diem Boutique _ DBH USA Diem Boutique _ DBH USA
Dallas

A Korean - American Skincare Brand

Westlake Dermatology University Park Westlake Dermatology University Park
6565 Hillcrest Ave., Suite 110
Dallas, 75205

Westlake Dermatology is a national leader in medical and aesthetic dermatology with offices located

Uptown Dermatology- Farhad Niroomand, M.D. Uptown Dermatology- Farhad Niroomand, M.D.
4144 N Central Expy, Ste 855
Dallas, 75204

Derm Texas Derm Texas
2110 Research Row
Dallas, 75235

We aim to provide our patients with cutting-edge and comprehensive dermatology care. From medical to cosmetic dermatology procedures delivered by a team of highly-trained professionals, we strive to ensure our patients receive the best possible care.

Davis Dermatology Davis Dermatology
6500 Greenville Ave
Dallas, 75206

http://www.LanceDavisMD.com

Max Adler, MD - Park Cities Dermatology Center Max Adler, MD - Park Cities Dermatology Center
8226 Douglas Ave
Dallas, 75225

Max F. Adler, M.D.